Richard Francis, newly-appointed Teva CEO (Novartis via Facebook)

New Te­va CEO Richard Fran­cis repri­or­i­tizes to 'get back to growth'

Six weeks in­to his new role at the helm of Te­va Phar­ma­ceu­ti­cal, Richard Fran­cis said it’s time to “get back to growth,” start­ing with a good look at the com­pa­ny’s pri­or­i­ties.

The chief ex­ec­u­tive has kicked off a strate­gic re­view, he an­nounced dur­ing Te­va’s quar­ter­ly call, which will con­tin­ue over the next sev­er­al months and pro­duce re­sults some­time in the mid­dle of 2023. That means some pipeline cuts may be in store, he told End­points News, while de­clin­ing to of­fer much more de­tail.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

Venture & Research Associate

Alexandria Real Estate Equities

San Francisco, CA, USA